Strategies for clinical dose optimization of T cell-engaging therapies in oncology
ABSTRACTInnovative approaches in the design of T cell-engaging (TCE) molecules are ushering in a new wave of promising immunotherapies for the treatment of cancer. Their mechanism of action, which generates an in trans interaction to create a synthetic immune synapse, leads to complex and interconne...
| Autors principals: | , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Taylor & Francis Group
2023-12-01
|
| Col·lecció: | mAbs |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2181016 |